WO2003059914A1 - An improved synthesis of ceftiofur intermediate - Google Patents

An improved synthesis of ceftiofur intermediate Download PDF

Info

Publication number
WO2003059914A1
WO2003059914A1 PCT/IB2002/000125 IB0200125W WO03059914A1 WO 2003059914 A1 WO2003059914 A1 WO 2003059914A1 IB 0200125 W IB0200125 W IB 0200125W WO 03059914 A1 WO03059914 A1 WO 03059914A1
Authority
WO
WIPO (PCT)
Prior art keywords
organic solvent
mixture
solution
formula
furyl
Prior art date
Application number
PCT/IB2002/000125
Other languages
French (fr)
Inventor
Pramod Narayan Deshpande
Bhausaheb Pandharinath Khadangale
Surulichamy Senthil Kumar
Gautam Kumar Das
Original Assignee
Orchid Chemicals & Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Chemicals & Pharmaceuticals Limited filed Critical Orchid Chemicals & Pharmaceuticals Limited
Priority to AU2002219436A priority Critical patent/AU2002219436A1/en
Priority to PCT/IB2002/000125 priority patent/WO2003059914A1/en
Publication of WO2003059914A1 publication Critical patent/WO2003059914A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Definitions

  • the present invention discloses an improved process for the preparation of 7-amino-3 -[2-
  • Ceftiofur is the generic name given to compound of formula (IN)
  • Ceftiofur acid, its alkali metal, alkaline earth metal and amines salts were reported for the first time in US patent no. 4464367.
  • the ceftiofur is a condensation product of 7-ACA with furyl-2-carbonylthiol and 2-(2-amino thiazol-4-yl)-2-methoxyimino) acetic acid at its 3 and 7 positions respectively.
  • 7-amino-3 - [2-furylcarb ⁇ nyl) thiomethyl]-3-cephem-4- carboxylic acid represented by formula (I) is the key intermediate which decides the quality and overall yield of the process for making ceftiofur.
  • the applicant provides for the first time an improved process for condensing 7-ACA with furyl-2-carbonylthiol which is generated and used in situ in the presence of borontriflouride in a gaseous state or its solution in an organic solvent to obtain compound of formula (I).
  • This process gives desired product of formula (I) in excellent yield (90-95%) and high purity (98-99%).
  • the primary object of the invention is to provide an improved and commercially viable efficient process for preparing 7-amino-3-[2-(furyicarbonyl)thiomethyl]-3-cephem-4- carboxylic acid (I), as an intermediate for ceftiofur.
  • Another object of the invention is to use furyl-2-carbonylthiol in situ without isolating it.
  • Yet another object of this invention is to provide a process which will give high yield and purity of the required product.
  • Still another object of the invention is to provide the use of boron trifluoride in gaseous state or its solution in an organic solvent for carrying out the condensation reaction at low temperature which are convenient for commercial production.
  • the present invention provides a process for the preparation of 3-[2-(fuxylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid (I) by the condensation of 7-aminocephalosporanic acid (II) with furyl-2-carbonylthiol (III) in the presence of borontrifluoride at a temperature range of 20°-50°C in an organic solvent. This process gives high yields and excellent purity.
  • the present invention provides a process for the preparation of 3-[2-(furylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid represented by formula (I),
  • An embodiment of the present invention provides a temperature range of 30°-35°C for performing the condensation reaction.
  • Another embodiment of the present invention provides a pH range of 3-4 and preferably 3.45-3.55 for the precipitation of the solid from the solution.
  • Yet another embodiment of the present invention provides the drying of the precipitated solid at a temperature range of 40°-45°C under vacuum.
  • One embodiment of the present invention provides the use of furyl-2-carbonylthiol in situ as a solution in an organic solvent.
  • Another embodiment of the present invention provides the use of organic solvent in the condensation reaction selected from group consisting of ethyl acetate, methyl acetate, propyl acetate, dichloromethane, toluene, diethyl ether, diisopropyl ether and/or mixture thereof.
  • organic solvent in the condensation reaction selected from group consisting of ethyl acetate, methyl acetate, propyl acetate, dichloromethane, toluene, diethyl ether, diisopropyl ether and/or mixture thereof.
  • base to adjust the pH of the reaction mixture is selected from a group consisting of ammonium hydroxide, sodium hydroxide or sodium carbonate.
  • Yet another embodiment of the present invention provides use of condensing agent borontriflouride in its gaseous form or its solution in an organic solvent.
  • the required product is obtained by precipitation and followed by filtration.
  • boron trifiuoride (124.0g) gas is purged into it.
  • 7-Amino-cephalosporanic acid (91.0 g ) is added at 10.0°C into the solution of borontrifluoride followed by the addition of furyl-2-carbonylthiol solution in ethylacetate (prepared above).
  • the reaction is completed by stirring for 4 -5 hr at 30-40°C.
  • the mixture is poured into ice cold water.
  • the pH of the solution is adjusted to 3.45-3.55 by addition of ammonium hydroxide.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

The present invention provides an improved process for the preparation of 7-amino-3-[2-(furylcarbonyl)thiomethyl]-3-cephem-4-carboxylic acid represented by formula (I) (I)by the condensation of 7-amino cephalosporanic acid (7-ACA) represented by formula (II) with furyl-2-carbonylthiol represented by formula (III) using borontrifluoride as condensing agent in an organic solvent at a temperature range of 20 °-50 °C.

Description

AN IMPROVED SYNTHESIS OF CEFTIOFUR INTERMEDIATE
TECHNICAL FIELD
The present invention discloses an improved process for the preparation of 7-amino-3 -[2-
(furylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid represented by formula (I)
Figure imgf000002_0001
(I) by the condensation of 7-amino cephalosporanic acid (7-ACA) represented by formula (II) with furyl-2-carbonylthiol represented by formula (III) using borontrifluoride as condensing agent.
Figure imgf000002_0002
(II) ("0
BACKGROUND ART
Ceftiofur is the generic name given to compound of formula (IN)
Figure imgf000002_0003
Ceftiofur acid, its alkali metal, alkaline earth metal and amines salts were reported for the first time in US patent no. 4464367. The ceftiofur is a condensation product of 7-ACA with furyl-2-carbonylthiol and 2-(2-amino thiazol-4-yl)-2-methoxyimino) acetic acid at its 3 and 7 positions respectively. 7-amino-3 - [2-furylcarbσnyl) thiomethyl]-3-cephem-4- carboxylic acid represented by formula (I) is the key intermediate which decides the quality and overall yield of the process for making ceftiofur. There are very few methods reported in the literature for the synthesis of 7-amino-3 - [2- (furylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid (I). The first report for the synthesis of this intermediate appeared in the US patent No. 4464367, wherein the method used for the preparation of the compound of Formula (I) was followed from a reference from the journal of Antibiotics 27,573-8,(1974) .This reference is about the condensation of 7 - aminocephalosporanic acid and sodium thiofuroate carried out at a pH of 6.4 using phosphate buffer .The reaction time is very long by following this tedious method and a yield is of 47% is reported for the final product. These limitations make this process unfavorable for commercial exploitation. Another method was disclosed in WO patent 87/01117 which is also merely an extension of the above-mentioned US patent. The condensation was effected by reaction of sodium thiofuroate and 7-ACA at a temperature of 65°C in an aqueous medium at a pH of 6.4. Cephalosporins are known to decompose at high temperature and moreover using this process, the reaction is not completed and yields are also very poor (about 45% and in addition, the reaction takes longer time, for example, even after several hours the reaction is incomplete).
Looking at all these problems, a method for the condensation under non-aqueous conditions was reported in US patent no. 5387679, where condensation of 7-ACA with heterocyclic thiols in the presence of complex of borontrifiouride with dialkyl carbonate was carried out to provide intermediates which are used in the synthesis of cephalosporin antibiotics.
When the process of US patent No. 5387679 is applied for the condensation of 7-ACA and furyl-2-carbonylthiol, the reaction mixture obtained is associated with several impurities, which could not be separated even during the final purification step. Later on, after several experimentation, the applicant found that the stability of furyl-2-carbonylthiol isolated in solid form is not encouraging. Further, this problem is encountered because furyl-2- carbonylthiol belongs to the class of heterocyclic thioacids and not heterocyclic thiol. The behavior of the reaction is not similar for the thioacids as it was for thiols thereby disallowing the conditions of the US patent No. 5387679 to be used in the present invention to achieve the final result.
In order to overcome this problem, the applicant provides for the first time an improved process for condensing 7-ACA with furyl-2-carbonylthiol which is generated and used in situ in the presence of borontriflouride in a gaseous state or its solution in an organic solvent to obtain compound of formula (I). This process gives desired product of formula (I) in excellent yield (90-95%) and high purity (98-99%).
DISCLOSURE OF THE INVENTION
The primary object of the invention is to provide an improved and commercially viable efficient process for preparing 7-amino-3-[2-(furyicarbonyl)thiomethyl]-3-cephem-4- carboxylic acid (I), as an intermediate for ceftiofur.
Another object of the invention is to use furyl-2-carbonylthiol in situ without isolating it.
Yet another object of this invention is to provide a process which will give high yield and purity of the required product.
Still another object of the invention is to provide the use of boron trifluoride in gaseous state or its solution in an organic solvent for carrying out the condensation reaction at low temperature which are convenient for commercial production.
SUMMARY OF THE INVENTION To meet the above objectives, the present invention provides a process for the preparation of 3-[2-(fuxylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid (I) by the condensation of 7-aminocephalosporanic acid (II) with furyl-2-carbonylthiol (III) in the presence of borontrifluoride at a temperature range of 20°-50°C in an organic solvent. This process gives high yields and excellent purity.
DETAILED DESCRIPTION OF THE INVENTION
The present invention provides a process for the preparation of 3-[2-(furylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid represented by formula (I),
Figure imgf000004_0001
(I) the said process comprising the steps of condensing 7-aminocephalosporanic acid (II) with f fuurryyll--22--ccaarrbboonnyylltthhiiooll iinn tthhee pprreesseennccee ooff bboorrontrifluoride at 20°-50°C in an organic solvent and isolating the compound of formula (I).
Figure imgf000005_0001
(II) (III)
In an embodiment of the present invention, the sequence of the present reaction is shown herebelowt
Figure imgf000005_0002
An embodiment of the present invention provides a temperature range of 30°-35°C for performing the condensation reaction.
Another embodiment of the present invention provides a pH range of 3-4 and preferably 3.45-3.55 for the precipitation of the solid from the solution.
Yet another embodiment of the present invention provides the drying of the precipitated solid at a temperature range of 40°-45°C under vacuum.
One embodiment of the present invention provides the use of furyl-2-carbonylthiol in situ as a solution in an organic solvent.
Another embodiment of the present invention provides the use of organic solvent in the condensation reaction selected from group consisting of ethyl acetate, methyl acetate, propyl acetate, dichloromethane, toluene, diethyl ether, diisopropyl ether and/or mixture thereof. One another embodiment of the present invention provides the use of base to adjust the pH of the reaction mixture is selected from a group consisting of ammonium hydroxide, sodium hydroxide or sodium carbonate.
Yet another embodiment of the present invention provides use of condensing agent borontriflouride in its gaseous form or its solution in an organic solvent.
Still yet another embodiment of the present invention, the required product is obtained by precipitation and followed by filtration.
The invention is illustrated with following examples, which should not be construed as limiting the scope of the invention.
Example -I 7-Amino - 3-(2-furylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid (I)
Charge sodium sulfϊde (54.6 g) in water (600ml) and furyl-2-carbonylchloride (50. Og) is added over a period of 60 minutes at a temperature of 20 C. Ethyl acetate is added to it and pH of the reaction mixture mass is adjusted to 1.0. The organic layer is separated, dried over anhydrous sodium sulphate, filtered to get furyI-2-carbonylthiol in ethyl acetate.
In an another flask ethylacetate (350ml) is charged, boron trifiuoride (124.0g) gas is purged into it. 7-Amino-cephalosporanic acid (91.0 g ) is added at 10.0°C into the solution of borontrifluoride followed by the addition of furyl-2-carbonylthiol solution in ethylacetate (prepared above). The reaction is completed by stirring for 4 -5 hr at 30-40°C. After completion of the reaction, the mixture is poured into ice cold water. The pH of the solution is adjusted to 3.45-3.55 by addition of ammonium hydroxide. The solid precipitated is filtered and washed with mixture of water and ethylacetate to get 7-amino - 3-(2-furylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid (I, HO.Og) with a purity of 98-99 % by HPLC.
Example -II
7-Amino - 3-(2-furylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid (T)
Charge sodium sulfide (36.4 g) in water (400ml) and furyl-2-carbonylchloride (33.3. Og) is added to it over a period of 60 minutes at a.temperature of 20°C. Ethyl acetate is added to it and pH of the reaction mixture is adjusted to 1.0. The organic layer is separated, dried over anhydrous sodium sulphate, filtered to get furyl-2-carbonylthiol in ethyl acetate. In an another flask acetonitrile (350ml ) is charged, boron trifluoride gas (85. Og) is purged into it. 7-Amino-cephalosporanic acid (60.6 g ) is added at 10.0°C into the solution of borontrifluoride, followed by the addition of furyl-2-carbonylthiol solution in ethylacetate (prepared above). The reaction is completed by stirring for 5 -6 hr at 30-40°C. After completion ofthe reaction, the mixture is poured into ice cold water. The pH of the solution is adjusted to 3.45-3.55 by addition ammonium hydroxide. The solid precipitated is filtered and washed with mixture of water and acetonitrile to get 7-amino - 3-(2-furylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid (I, 69. Og) with a purity of 97-98 % by HPLC.
Example -III 7-Amino - 3-(2-furyIcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid (I)
Charge sodium sulfide (54.6 g) in water (600mi) and furyl-2-carbonylchloride (50.0g) is added to it over a period of 60 minutes at a temperature of 20°C. Ethyl acetate is added to it and pH of the mixture is adjusted to 1.0 by adding hydrochloric acid. The organic layer is separated, dried over anhydrous sodium sulphate, filtered to get furyl-2-carbonylthiol in ethyl acetate.
In an another flask containing acetonitrile (350ml) is added 7-Amino-cephalosρoranic acid (91.0 g) at room temperature followed by addition of 45-48% solution of boron trifluoride etherate (275.5ml) at a temperature of 10.0°C. To this added furyl-2-carbonylthiol solution in ethylacetate (prepared above) and the reaction is completed by stirring for 4 -5 hr at 40- 50°C. After completion of the reaction, the mixture is poured into ice cold water. The pH ofthe solution is adjusted to 3.45-3.55 by addition of sodium carbonate solution . The solid precipitated is filtered and washed with mixture of water and ethylacetate to get 7-amino- 3-(2-furylcarbonyl) thiomethyl]-3-cephem-4-carboxylic acid (I, 104.0g) with a purity of 97-98 % by HPLC .

Claims

We claim:
1. A process for the preparation of 3-[2-(furylcarbonyl) thiomethyl]-3-cephem-4- carboxylic acid represented by formula (I),
Figure imgf000008_0001
(I) the said process comprising the step of condensing 7-aminocephalosporanic acid
(II) with furyl-2-carbonylthiol (III) in the presence of borontrifluoride at 20-50°C in an organic solvent and isolating the compound of formula (I)
Figure imgf000008_0002
(II) (III)
2. A process as claimed in claim 1, wherein the condensation reaction is performed at a temperature range of 30°-35°C.
3. A process as claimed in claim 1, wherein the reaction mixture of condensation is poured into ice cold water, adjusting the pH of the solution to 3-4 with a base to precipitate the solid.
4. A process as claimed in claim 3, wherein the pH of the solution is in the range between 3.45—3.55.
5. A process as claimed in claim 3, wherein the solid obtained by precipitation is washed with a mixture of water and organic solvent, drying the solid at a temperature range of 40°-45°C under vacuum.
6. A process as claimed in claim 1, wherein furyl-2-carbonylthiol of formula (III) without isolation, is used as its solution in an organic solvent selected from a group consisting of ethylacetate, methyl acetate, propyl acetate, dichloromethane, toluene, diethyl ether, di-isopropyl ether and/or mixture thereof.
7. A process as claimed in claim 1, wherein the organic solvent used in the condensation reaction is selected from a group consisting of ethylacetate, methyl acetate, propyl acetate, dichloromethane, toluene, diethyl ether, di-isopropyl ether, acetonitrile, acetic acid or mixture thereof, most preferably ethyl acetate.
8. A process as claimed in claim 1, wherein the condensing agent borontrifluoride is used in a gaseous form or its solution in an organic solvent selected from ethyl acetate, acetonitrile, methyl acetate, propyl acetate, dichloromethane, toluene, diethyl ether, di-isopropyl ether and/or mixture thereof, most preferably in gaseous form.
9. A process as claimed in claim 1, wherein 3-8 moles of borontrifluoride is used with respect to 7-aminocephalosporanic acid, the preferred molar ratio being 4.5:1.
10. A process as claimed in claim 3, wherein the base used is selected from a group consisting of ammonium hydroxide, sodium hydroxide, or sodium carbonate and most preferably ammonium hydroxide.
11. A process as claimed in claim 5, wherein the organic solvent used for washing the final product is selected from a group consisting of acetonitrile, ethylacetate, acetone, methyl acetate, propyl acetate, dichloromethane, toluene, diethyl ether,di- isopropyl ether and/or mixture thereof.
PCT/IB2002/000125 2002-01-15 2002-01-15 An improved synthesis of ceftiofur intermediate WO2003059914A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002219436A AU2002219436A1 (en) 2002-01-15 2002-01-15 An improved synthesis of ceftiofur intermediate
PCT/IB2002/000125 WO2003059914A1 (en) 2002-01-15 2002-01-15 An improved synthesis of ceftiofur intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/000125 WO2003059914A1 (en) 2002-01-15 2002-01-15 An improved synthesis of ceftiofur intermediate

Publications (1)

Publication Number Publication Date
WO2003059914A1 true WO2003059914A1 (en) 2003-07-24

Family

ID=11004265

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/000125 WO2003059914A1 (en) 2002-01-15 2002-01-15 An improved synthesis of ceftiofur intermediate

Country Status (2)

Country Link
AU (1) AU2002219436A1 (en)
WO (1) WO2003059914A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100502390B1 (en) * 2001-09-07 2005-07-19 주식회사 엘지생명과학 Process for preparing cephalosporinic acid
CN102234289A (en) * 2010-05-02 2011-11-09 青岛科技大学 Novel method for preparing ceftiofur intermediate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464367A (en) * 1980-03-26 1984-08-07 Sanofi Cephalosporin derivatives, process for preparation thereof and drugs containing said derivatives usable as antibiotics

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464367A (en) * 1980-03-26 1984-08-07 Sanofi Cephalosporin derivatives, process for preparation thereof and drugs containing said derivatives usable as antibiotics

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE CASREACT [online] ZHU Y. ET AL.: "Synthesis of ceftiofur", accession no. STN Database accession no. 136:309780 *
ZHONGGUO YIYAO GONGYE ZATHI, vol. 32, no. 6, 2001, pages 241 - 242 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100502390B1 (en) * 2001-09-07 2005-07-19 주식회사 엘지생명과학 Process for preparing cephalosporinic acid
CN102234289A (en) * 2010-05-02 2011-11-09 青岛科技大学 Novel method for preparing ceftiofur intermediate
CN102234289B (en) * 2010-05-02 2013-07-10 青岛科技大学 Novel method for preparing ceftiofur intermediate

Also Published As

Publication number Publication date
AU2002219436A1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
US7825241B2 (en) Cefdinir intermediate
US7452990B2 (en) Intermediates for synthesis of cephalosporins and process for preparation of such intermediates
US20030135041A1 (en) Synthesis of ceftiofur intermediate
CA2433783A1 (en) Novel thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds
US4482710A (en) Process for preparing 3-alkoxymethylcephalosporin derivatives
WO2005100369A1 (en) Depletion of e-isomers in preparation of z-enriched 3-(2-substituted vinyl) cephalosporins
WO2005019227A1 (en) Process for the preparation of cephalosporin antibiotic
JP2006511561A (en) Crystalline cefdinir salt
US20150073138A1 (en) Novel process for preparing ceftaroline fosamil
WO2011042776A1 (en) Process for preparation of cefotaxime acid and pharmaceutically acceptable salt thereof
WO2003093278A2 (en) Process for the preparation of ceftiofur acid
WO2003059914A1 (en) An improved synthesis of ceftiofur intermediate
WO2008041100A1 (en) Improved process for the preparation of cephalosporin antibiotics
WO2004037833A1 (en) Process for the preparation of cephalosporin antibiotics
NO164772B (en) PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINE DERIVATIVES.
EP1268488B1 (en) A process for preparing cephalosporin derivatives using new thiazole compound
US20100261897A1 (en) Improved Process For the Preparation of Cephalosporin Antibiotic Intermediate
US6448393B1 (en) Process for producing 3-cephem compounds
US7335767B2 (en) Method for preparation of ceftiofur and salts thereof
HU213267B (en) Process for producing stereospecific cefepime-dihydrochloride-hydrate at ph 5-7,5
WO2011042775A1 (en) Process for preparation of cefotaxime acid
WO2005076694A2 (en) Improved process for the production of cefotaxime sodium
KR100355115B1 (en) New cephem compouns for preparation of ceftiofur
US4008228A (en) Process for preparing 3-methyl-3-cephem antibiotics
EP0382220A2 (en) Method for preparing aminothiazolylacetic acid derivatives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP